CAS: 110-51-0; Borane-Pyridine Complex

该化合物是一种该化合物是一种方便的borane来源,与气态BH3相比,它提供了受控的回活性和增强的安全性.该综合物因其在减少反应方面的作用而特别受到重视,包括有选择地减少对酒精的碳oxylic酸和对藻类进行水化.其固态形式可以确保易于处理和精确的剂量,而其中度稳定性允许在温和条件下逐步释放borane.该产品被广泛用于制药和精细化学合成,提供一贯的性能和再生性能.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号110-86-1 吡啶 | CAS号16940-66-2 硼氢化钠 | CAS号628-13-7 吡啶盐酸盐 | CAS号19287-45-7 乙硼烷 | CAS号42976-02-3 hexamethylene t... | CAS号10544-50-0 1,2,3,4,5,6,7,8... | CAS号61289-01-8 [(EtH2N)B8H11NHEt] | CAS号1333-74-0 氢 | CAS号10294-34-5 三氯化硼 | CAS号244761-17-9 lithium tetrahy... | CAS号14289-74-8 tris(2,4,4-trim... | CAS号446065-11-8 环己基三氟硼酸钾 | CAS号1883-35-8 tris(2-phenylet... | CAS号23985-40-2 tricyclopentylborane | CAS号110-86-1 吡啶 | CAS号121-43-7 硼酸三甲酯 | CAS号1333-74-0 氢 | CAS号10043-11-5 氮化硼 | CAS号688-71-1 硼酸三丙酯 | CAS号150-46-9 硼酸三乙酯

合成工艺路线路线简述

    Diborane(6)置于吡啶体系中,用 Neat (No Solvent) 用作溶剂,化学反应生成吡啶硼烷
    参考文献:Brown,Herbert C.; Murray,Leo T.,Inorganic Chemistry,1984,Vol. 23,# 18,P. 2746-2753
    标题:Brown,Herbert C.; Murray,Leo T.,Inorganic Chemistry,1984,Vol. 23,# 18,P. 2746-2753

    海关参考信息

    专利信息


    专利号:US-2008032964-A1
    优先权日:2006-04-10
    标题:Process for the synthesis of azetidinone
    发明人:KANSAL VINOD K; AHMAD SUHAIL; MARIAPPAN SHANMUGAVEL; TYAGI BHUPENDRA; PERLMAN NURIT; LE PAIH JACQUES; ZANOTTI-GEROSA ANTONIO
    权利人:KANSAL VINOD K; AHMAD SUHAIL; MARIAPPAN SHANMUGAVEL; TYAGI BHUPENDRA; PERLMAN NURIT; LE PAIH JACQUES; ZANOTTI-GEROSA ANTONIO
    摘要:Provided are intermediates useful for the synthesis of hydroxyl-alkyl substituted azetidinones, processes of their preparation, and processes for the synthesis of certain hydroxyl-alkyl substituted azetidinones. Also provided are processes for the synthesis of 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone, or ezetimibe.

    专利号:US-7767826-B2
    优先权日:2007-10-05
    标题 :Process for the synthesis of L-(+)-ergothioneine
    发明人:TRAMPOTA MIROSLAV
    权利人:PHARMATECH INTERNATIONAL INC
    摘要:This invention relates to a novel process for the preparation of optically pure L-(+)-ergothioneine. The process for the chemical synthesis of L-ergothioneine comprises steps which consist of reacting L-histidine alkyl ester with an acid halide, chloroformate or pyrocarbonate in the presence of a base, hydrolysis of the alkyl-(S,Z)-2,4,5-triamidopent-4-enoate to obtain a (S)-alkyl 2,5-diamido-4-oxopentanoate, acid catalyzed hydrolysis of the (S)-alkyl 2,5-diamido-4-oxopentanoate followed by reaction with a metal thiocyanate to obtain the thiohistidine, protection of the sulfur of thiohistidine as the tert-butyl thioether, dialkylation of the primary amine to obtain a tertiary amine, quaternization of the tertiary amine, and removal of the protecting group to obtain the desired (S)-3-(2-mercapto-1H-imidazol-5-yl)-2-(trialkylammonio)propanoate (I). This process affords a better yield and is capable of practical application at large scale.

    专利号:US-10370403-B2
    优先权日:2015-04-22
    标题 :Methods for the synthesis of ceragenins
    发明人:SAVAGE PAUL B; JACKS THOMAS E; MILLER ROSS A; THOMPSON ANDREW S; RANDALL JARED LYNN
    权利人:SAVAGE PAUL B; JACKS THOMAS E; MILLER ROSS A; THOMPSON ANDREW S; RANDALL JARED LYNN; UNIV BRIGHAM YOUNG
    摘要:Disclosed herein are methods of making ceragnenin compounds for treating, preventing, or diagnosing diseases, disorders, or conditions associated with bacterial or viral infections, cancer, inflammation, and osteogenesis. Ceragenin compounds display broad-spectrum antibacterial activity utilizing a mode of action similar to antimicrobial peptides, but without the high synthesis costs and susceptibility to proteolytic degradation. Ceragenin compounds reproduce the amphiphilic morphology found in many antimicrobial peptides and display potent and diverse biological activities, including anti-bacterial, anti-cancer, anti-inflammatory, bone growth promotion, and wound healing promotion.

    专利号:US-2006241298-A1
    优先权日:2005-04-21
    标 题:Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
    发明人:MORTKO HENRY; HE WEIXUAN; ANDERSEN MARC W; DOTSE ANTHONY K; LI JIE
    权利人:MORTKO HENRY; HE WEIXUAN; ANDERSEN MARC W; DOTSE ANTHONY K; LI JIE
    摘要:Disclosed is a method of making 2-substituted-2-halo-1,3-propanediols via reduction of corresponding malonate compounds. Also disclosed is a method of making 2-substituted-2-halo-1,3-dicarbamate compounds (such as halo derivatives of felbamate, including fluorofelbamate) via reduction of malonate compounds, followed by carbamoylation. Reduction of the malonate compounds is carried out using an electrophilic hydride reagent.

    专利号:US-9125880-B2
    优先权日:2002-12-26
    标 题:Polymer conjugates of interferon-beta with enhanced biological potency
    发明人:SAIFER MARK G P; MARTINEZ ALEXA L; WILLIAMS L DAVID; SHERMAN MERRY R
    权利人:SAIFER MARK G P; MARTINEZ ALEXA L; WILLIAMS L DAVID; SHERMAN MERRY R; MOUNTAIN VIEW PHARMACEUTICALS
    摘要:Methods are provided for the synthesis of polymer conjugates of cytokines and receptor-binding antagonists thereof, especially a non-glycosylated interferon-beta, which conjugates retain unusually high biological potency. Preparation of polymer conjugates according to the methods of the present invention diminishes or avoids steric inhibition of receptor-ligand interactions that commonly results from the attachment of polymers to receptor-binding regions of cytokines, as well as to agonistic and antagonistic analogs thereof. The invention also provides conjugates and compositions produced by such methods. The conjugates of the present invention retain a high level of biological potency compared to those produced by traditional polymer coupling methods that are not targeted to avoid receptor-binding domains of cytokines. In assays in vitro, the biological potency of the conjugates of non-glycosylated interferon-beta of the present invention is substantially higher than that of unconjugated interferon-beta and is similar to that of interferon-beta-1a that is glycosylated. The conjugates of the present invention also exhibit an extended half-life in vivo compared to the corresponding unconjugated cytokine. The present invention also provides kits comprising such conjugates and/or compositions, and methods of use of such conjugates and compositions in a variety of diagnostic, prophylactic and therapeutic applications, including treatment of multiple sclerosis.

    专利号:US-5663368-A
    优先权日:1993-07-14
    标 题:Synthesis of acid addition salts of hydroxylamines
    发明人:FLISAK JOSEPH R; ROSS STEPHEN TOREY
    权利人:SMITHKLINE BEECHAM CORP
    摘要:This invention relates to novel diastereomeric acid addition salts of homochiral hydroxylamines, to processes for obtaining such, to processes for the conversion thereof to the corresponding homochiral hydroxylamines, to certain novel homochiral hydroxylamines and the processes for using these as intermediates.
    上海福兴医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.forxine.com
    电话:021-64961388,64961699👤
    📞 上海福兴医药科技有限公司⚠️参考联系方式

    电话: 021-64961388,64961699
    邮件:service@forxine.com
    网址: http://www.forxine.com
    地址:上海市闵行区都会路1835号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    上海市闵行区都会路1835号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    郑州今斯孚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kingsfine.com/index.html
    电话: 0371-56632527 13838252817👤
    📞郑州今斯孚化学有限公司 ⚠️参考联系方式

    销售电话:0371-56632527 13838252817
    邮箱:sales@kingsfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    山东英朗化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sdylhg.com
    企业联系电话:赵经理15098730035;李经理18353107508👤
    📞山东英朗化工有限公司 ⚠️参考联系方式
    联系人:赵经理
    电话:赵经理15098730035;李经理18353107508

    传真:外贸:徐经理18253159658
    邮箱:sales@sdkaiyue.com
    通信地址: 山东省济南市CBD片区华润置地广场6区2号楼6层
    邮编: 250000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东省济南市CBD片区华润置地广场6区2号楼6层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    威智医药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.viwit.com
    电话:0632-2980981;15063270987👤
    📞 威智医药股份有限公司⚠️参考联系方式

    电话: 0632-2980981;15063270987
    邮件:service.china3@viwit.com
    网址: http://www.viwit.com
    地址:山东省滕州市生物医药产业基地威智大道88号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    山东省滕州市生物医药产业基地威智大道88号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Casey J Krusemark, Et Al. Global Amine And Acid Functional Group Modification Of Proteins. Anal Chem. 2008 Feb 1;80(3):713-20.
    [参考文献]: Christin Striegler, Et Al. Dendritic Glycopolymer As Drug Delivery System For Proteasome Inhibitor Bortezomib In A Calcium Phosphate Bone Cement: First Steps Toward A Local Therapy Of Osteolytic Bone Lesions. Macromol Biosci. 2015 Sep;15(9):1283-95.
    [参考文献]: Julia M Clay, Et Al. Hydroboration With Pyridine Borane At Room Temperature. J Am Chem Soc. 2005 Apr 27;127(16):5766-7.
    [参考文献]: Matthew A Zajac, Et Al. An Application Of Borane As A Protecting Group For Pyridine. J Org Chem. 2008 Sep 5;73(17):6899-901.
    [参考文献]: W S Wong, Et Al. Pyridine Borane As A Reducing Agent For Proteins. Anal Biochem. 1984 May 15;139(1):58-67.

    合成参考文献


    摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2026).
    参考文献:10.1007/978-1-61779-148-2_6
    摘要:Krusemark CJ, Frey BL, Smith LM, Belshaw PJ. Complete chemical modification of amine and acid functional groups of peptides and small proteins. Methods Mol Biol. 2011;753():77–91.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知